Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Compartmentalized organization might be crucial for stem cells to effectively respond to growth or injury.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Genetic mutations can affect female sexual development, requiring personalized medical care.

c-Myc activation in mouse skin increases sebaceous gland growth and affects hair follicle development.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.